Dr Sergei Sokolovski of the University's Aston Institute of Photonic Technologies has been awarded €317,500 to work on a European-wide project.
Called BETTER (Better real-world health data distributed analytics research platform) the spans16 academic, medical and industrial partners.
Predicting how molecules will react is vital for the discovery and manufacture of new pharmaceuticals, but historically this has been a trial-and-error process, and the reactions often fail.
Each of the five main stages run across the two-days of Rewired24 which will run at the NEC Birmingham, packed with original keynotes, inspiring NHS case studies, panel sessions and lively Rewired debates.